Neil Klinger MD

Neil Klinger MD

Neil Klinger MD

Narrative Bio

Neil Klinger grew up in northern Michigan. He attended Grand Valley State University for his bachelor's degree. He then pursued a master’s degree researching the protein chemistry of enzymes involved in bacterial antibiotic resistance. While attending Wayne State University School of Medicine, his interest in research led him to work on neuro-oncology projects in Dr. Sandeep Mittal’s lab. In his spare time, Neil enjoys spending time with his family and cooking.

Residency

2017-Present
Neurosurgery
Wayne State University/Detroit Medical Center
Detroit, Michigan

Publications

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhasz C: Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg:1-8, 2017

Bosnyak E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, et al: Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma. Clin Nucl Med 42:341-347, 2017

Michelhaugh SK, Muzik O, Guastella AR, Klinger NV, Polin LA, Cai H, et al: Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and alpha-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts. J Nucl Med 58:208-213, 2017

Klinger NV, Shah AK, Mittal S: Management of brain tumor-related epilepsy. Neurol India 65:S60-s70, 2017

Guastella AR, Michelhaugh SK, Klinger NV, Kupsky WJ, Polin LA, Muzik O, et al: Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma. Mol Imaging 15, 2016

Klinger NV, Mittal S: Therapeutic Potential of Curcumin for the Treatment of Brain Tumors. Oxid Med Cell Longev 2016:9324085, 2016

Klinger NV, Mittal S: Clinical efficacy of deep brain stimulation for the treatment of medically refractory epilepsy. Clin Neurol Neurosurg 140:11-25, 2016

Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, et al: Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med 13:227, 2015

Mitchell JM, Clasman JR, June CM, Kaitany KC, LaFleur JR, Taracila MA, Klinger NV, et al: Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D beta-lactamases from Acinetobacter baumannii. Biochemistry 54:1976-1987, 2015

Kaitany KC, Klinger NV, June CM, Ramey ME, Bonomo RA, Powers RA, et al: Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam. Antimicrob Agents Chemother 57:4848-4855, 2013